AZD2516

DRUG4 trials

Sponsors

AstraZeneca

Conditions

HealthyPart A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years.Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80

Phase 1

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers

CompletedNCT00754715

AstraZenecaHealthy

Start: 2008-09-30End: 2008-12-31Target: 72Updated: 2008-12-15

An Open Label Positron Emission Tomography (PET) Study to Determine Central mGluR5 Receptor Occupancy of AZD2516

CompletedNCT00892944

AstraZenecaHealthy

Start: 2009-04-30End: 2009-10-31Target: 6Updated: 2009-10-28

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Dose of AZD2516 to Japanese Healthy Subjects

CompletedNCT00972049

AstraZenecaHealthy

Start: 2009-09-30End: 2009-12-31Updated: 2010-03-04

To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy Volunteers

CompletedNCT01148095

AstraZenecaPart A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years., Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80

Start: 2010-06-30End: 2010-07-31Updated: 2011-02-08